DuPont Q2 2026 beats guidance; raises full-year outlook; adjusted EPS $1.88, up 48% YoY

DuPont de Nemours, Inc.

Net sales $1.819B (+4% YoY); organic sales +4%; GAAP EPS $1.37 vs $0.17 prior year.
Operating EBITDA $448M (+6%); adjusted EPS $1.88 (+48%); transaction-adjusted FCF $326M (127% conversion).
Healthcare & Water Technologies sales $856M (+5% YoY); Diversified Industrials sales $963M (+3%).
Raised FY2026 guidance: net sales $7.16-7.19B, operating EBITDA $1.75-1.77B, adjusted EPS $7.17-7.32.
Announces $250M share repurchase in Q3; GICS reclassified to Industrials effective July 31, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.